-
How is pharmacovigilance done
Time of Update: 2022-02-23
The World Health Organization has a specific definition of this term, which is called the discovery, assessment, understanding and prevention of adverse drug reactions or any other drug-related problems, sciences and activities .
-
Is the CXO sector still optimistic
Time of Update: 2022-01-22
With the transfer of global pharmaceutical giants' R&D links to China, as well as the enthusiasm for new drug R&D, coupled with policy immunity, pharmaceutical research and production outsourcing services (CXO) can be said to be a sweet pastry in the pharmaceutical market .
-
my country's first third-generation BCR-ABL inhibitor oribatinib was launched, hitting CML resistance
Time of Update: 2022-01-10
It is understood that oribatinib has been approved by the National Medical Products Administration (NMPA) of China on November 25 for the treatment of resistance to any tyrosine kinase inhibitor (TKI), and uses fully validated The detection method diagnoses adult patients with chronic myeloid leukemia (CML) with T315I mutation in the chronic phase (CP) or accelerated phase (AP) .
-
National procurement has landed, the two provinces do not engage in "one size fits all", and the allocation ratio of unselected varieties in Shanghai is about 20
Time of Update: 2021-11-01
On October 14th, Jiangsu Province issued the "Notice on Doing a Good Job in the Implementation of the Fifth Batch of Nationally Organized Drug Centralized Procurement Results", clarifying that the procurement price will be switched from the provincial platform at 24:00 on October 25; 24:00 on October 31 Start execution .
-
Abamectin drug residue determination method (3
Time of Update: 2021-10-22
used ESI positive ion mode to detect AVM, IVM, EPR, DOR and MOX residues in beef liver .
In the negative ion mode, using triethylamine-acetonitrile as the mobile phase, using SEL as the internal standard, the linear range of AVM, DOR, IVM, EPR and MOX is 1～60μg/kg, and the method LOD is 0.
-
Shanghai Pharmaceuticals duloxetine hydrochloride enteric-coated tablets passed the consistency evaluation of generic drugs
Time of Update: 2021-06-17
(hereinafter referred to as “Shanghai Pharmaceuticals Zhongxi”) has received the relevant duloxetine hydrochloride enteric-coated tablets issued by the State Food and Drug Administration.
In January 2020, Shanghai Pharmaceuticals Zhongxi submitted an application to the State Food and Drug Administration for the consistency evaluation of the generic drug and was accepted .
-
Merck's molnupiravir treatment of mild to moderate COVID-19 outpatients enters Phase 3 clinical trials
Time of Update: 2021-04-23
At present, the new crown pneumonia epidemic abroad is still spreading rapidly. According to Baidu's "New Coronavirus Pneumonia Epidemic Real-time Big Data Report", as of 00:00 on April 18, 2021, the
-
The phase 3 trial of CC-486 maintenance therapy obtained positive results
Time of Update: 2021-02-22
Today, As a maintenance therapy, CC-486 achieved statistically and clinically significant improvements in total survival (OS) and recurrence (RFS) compared to placebos in phase 3 critical trial QUAZAR AML-001 for patients treating acute myeloid leukemia (AML).
-
Injection of monoclonal antibodies can reduce the concentration of new coronaviruses in the nose
Time of Update: 2021-01-29
. drugmaker Lilly said on January 21st that its antibody drugs could prevent residents and staff in nursing homes and other long-term care facilities from developing new coronary pneumonia.
-
The re-adjustment of the health insurance catalogue has allowed people's livelihood and welfare to rise rapidly
Time of Update: 2021-01-21
the pace of adjustment, the Medicare drug catalog will no longer be a "safe deposit box." Interim Measures for the Administration of Drug Use in Basic Medical Insurance clearly stipulate that medicines that are guaranteed priority for medical insurance, and non-essential drugs such as medicines and health care drugs, which mainly play a tonic role, will no longer be included in the catalogue.
-
Announcement of Food Safety Supervision and Sampling Information of the Food Safety Supervision and Administration of Guangxi Zhuang Autonomous Region (No. 39, 2018 No. 160
Time of Update: 2021-01-08
(v) Mengshan County Chushi Rongheng Food Factory sales of the label "Guangxi Ganzhou City, Mengshi Rongheng Food Factory" production of "fresh wet rice flour (cut powder)" samples (trademark:/, production date: 2018-07-20, specifications: net content: 5 kg), the total detection value of the bacteria is 1.4×107CFU/g, 4.107CFU 1×106CFU/g, 5.2×106CFU/g, 1.3×107CFU/g, 9.8×106CFU/g, the standard check-out value is n=5, c=2,m=105CFU/g, M=106CFU/g.
-
China's AIDS vaccine "win" geometry
Time of Update: 2020-12-22
, the CDC vaccine team led by Nie Yiming has selected a replica viral vector carrier to conduct the first phase of the vaccine research clinical trial, which showed good safety.
-
Colorectal cancer genetic testing allows doctors to accurately determine the status of tumor patients
Time of Update: 2020-08-06
recently at an academic conference on colorectal cancer, domestic bowel cancer experts said that "precision medicine" model has arrived, recommended that patients with a family adenoma polyps, digestive system or urinary system tumor history of early genetic testing related to colorectal cancer, so that doctors can make accurate judgments, guide prevention and treatment.
-
A batch of drugs were inspected and the drug regulator requested to stop selling recall pharmacies to quickly check
Time of Update: 2020-07-23
On July 9, , the Shandong Provincial Drug Administration issued the 4th Issue of 2020 Drug Quality Sampling Notice (hereinafter referred to as the "Notice") notice pointed out that in order to streng
-
Research and development of daily news yjunshi new crown neutralizing antibodies into Phase I clinical and completed the first drug administration
Time of Update: 2020-07-09
Novartis triple therapy Enerzair Breezhale treatment asthma phase IIIb clinical primary endpoint; BI Nidanib China approved for the treatment of scleronopathic-related interstitial lung disease; Gua
